MEDICINE
“ Mothers talk about meeting their children ‘ for the first time ’ at the age of 10 when , thanks to a simple plant medicine , they finally have the opportunity to go to school after being prisoners in their own bodies for so long ”
– John-David Belfontaine , Founder and CEO of Phivida
clinical research on cannabinoids has already captured the attention of healthcare practitioners , regulators , professional athletes and the media , which is why investors are so keenly interested in the industry ,” Belfontaine says . “ One of the factors that sets Phivida apart is our unwavering support for research and education into this important field of health and wellness , and our commitment to apply what we learn to benefit families . Appointing our clinical advisory team is an important first step in that process .”
Phivida ’ s clinical advisory team includes Dr Sunil Pai , Dr Joost Luecker , Dr Brian Martin and Dr Chris Meletis – all naturopathic MDs with PHDs in Botany . They have taken Phivida ’ s analysis on clinical trials previously performed around the world and compiled it into a concise literature review format for medical practitioner review . “ We ’ ve created a seminar series to go around universities and educate
48 April 2018